AT345449B - Verfahren zur herstellung von influenzavirus-bestandteilen - Google Patents

Verfahren zur herstellung von influenzavirus-bestandteilen

Info

Publication number
AT345449B
AT345449B AT21475A AT21475A AT345449B AT 345449 B AT345449 B AT 345449B AT 21475 A AT21475 A AT 21475A AT 21475 A AT21475 A AT 21475A AT 345449 B AT345449 B AT 345449B
Authority
AT
Austria
Prior art keywords
influenzavirus
producing
components
producing influenzavirus
influenzavirus components
Prior art date
Application number
AT21475A
Other languages
German (de)
English (en)
Other versions
ATA21475A (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of ATA21475A publication Critical patent/ATA21475A/de
Application granted granted Critical
Publication of AT345449B publication Critical patent/AT345449B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AT21475A 1974-01-14 1975-01-13 Verfahren zur herstellung von influenzavirus-bestandteilen AT345449B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (zh) 1974-01-14 1974-01-14

Publications (2)

Publication Number Publication Date
ATA21475A ATA21475A (de) 1978-01-15
AT345449B true AT345449B (de) 1978-09-11

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
AT21475A AT345449B (de) 1974-01-14 1975-01-13 Verfahren zur herstellung von influenzavirus-bestandteilen

Country Status (27)

Country Link
JP (2) JPS58407B2 (zh)
AT (1) AT345449B (zh)
AU (1) AU500250B2 (zh)
BE (1) BE824372A (zh)
CA (1) CA1049406A (zh)
CH (1) CH589453A5 (zh)
CS (1) CS191254B2 (zh)
DD (1) DD116239A5 (zh)
DE (1) DE2500785B2 (zh)
DK (1) DK140003B (zh)
ES (1) ES433759A1 (zh)
FI (1) FI54053C (zh)
FR (1) FR2257305B1 (zh)
GB (1) GB1498261A (zh)
HK (1) HK56380A (zh)
HU (1) HU173920B (zh)
IE (1) IE40794B1 (zh)
IL (1) IL46426A (zh)
MY (1) MY8100204A (zh)
NL (1) NL166622C (zh)
NO (1) NO143128C (zh)
PH (1) PH14458A (zh)
PL (1) PL93689B1 (zh)
SE (1) SE427238B (zh)
SU (1) SU616997A3 (zh)
YU (1) YU41289B (zh)
ZA (1) ZA75259B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
AU2006310171B2 (en) * 2005-11-01 2011-02-17 Seqirus UK Limited Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment
RU2496519C2 (ru) 2007-08-28 2013-10-27 Бакстер Интернэшнл Инк. Способ получения препарата, содержащего вирусные антигены, и применение препарата
JP6373376B2 (ja) 2013-11-15 2018-08-15 ノバルティス アーゲー 残留細胞培養不純物の除去

Also Published As

Publication number Publication date
DK140003C (zh) 1979-10-29
MY8100204A (en) 1981-12-31
HU173920B (hu) 1979-09-28
GB1498261A (en) 1978-01-18
IL46426A0 (en) 1975-04-25
DK1475A (zh) 1975-09-01
FR2257305A1 (zh) 1975-08-08
FI54053B (fi) 1978-06-30
DE2500785A1 (de) 1975-07-31
DK140003B (da) 1979-06-05
NL166622C (nl) 1981-09-15
ATA21475A (de) 1978-01-15
IE40794B1 (en) 1979-08-15
CH589453A5 (zh) 1977-07-15
CS191254B2 (en) 1979-06-29
YU41289B (en) 1987-02-28
AU7730575A (en) 1976-07-15
PL93689B1 (zh) 1977-06-30
SU616997A3 (ru) 1978-07-25
NO143128B (no) 1980-09-15
AU500250B2 (en) 1979-05-17
PH14458A (en) 1981-07-29
DD116239A5 (zh) 1975-11-12
JPS50100224A (zh) 1975-08-08
NL7500301A (nl) 1975-07-16
FI54053C (fi) 1978-10-10
CA1049406A (en) 1979-02-27
DE2500785C3 (zh) 1980-09-11
HK56380A (en) 1980-10-16
ES433759A1 (es) 1977-02-16
JPS58407B2 (ja) 1983-01-06
DE2500785B2 (de) 1980-01-03
NL166622B (nl) 1981-04-15
YU5875A (en) 1984-04-30
IL46426A (en) 1978-01-31
JPS56127319A (en) 1981-10-06
NO143128C (no) 1980-12-29
ZA75259B (en) 1976-08-25
BE824372A (fr) 1975-07-14
NO750031L (zh) 1975-08-11
JPS6035326B2 (ja) 1985-08-14
FR2257305B1 (zh) 1982-03-19
SE427238B (sv) 1983-03-21
FI750014A (zh) 1975-07-15
SE7500130L (zh) 1975-07-15
IE40794L (en) 1975-07-14

Similar Documents

Publication Publication Date Title
AT351008B (de) Verfahren zur herstellung von mercaptanen
AT335995B (de) Verfahren zur herstellung von ketoisophoron
AT370714B (de) Verfahren zur herstellung von aldehyden
AT336633B (de) Verfahren zur herstellung von monomethylzinntrihalogeniden
AT338232B (de) Verfahren zur herstellung von ketoisophoron
AT342015B (de) Verfahren zur herstellung von acetoacetamid-n-sulfofluorid
AT345449B (de) Verfahren zur herstellung von influenzavirus-bestandteilen
AT329586B (de) Verfahren zur herstellung von organophosphinen
AT344136B (de) Verfahren zur herstellung von neuem 2-deutero-3-fluor-dl-alanin
ATA425375A (de) Verfahren zur herstellung von prostaglandinartigen (d1)-verbindungen
AT349487B (de) Verfahren zur herstellung von symmetrischen harnstoffen
DD130933A5 (de) Verfahren zur herstellung von sulfinylazetidinonen
AT360491B (de) Verfahren zur herstellung von hexagonalem bornitrid
AT351523B (de) Verfahren zur herstellung von 2-alkyl-5- nitroimidazolderivaten
AT335609B (de) Verfahren zur herstellung von cephemverbindungen
AT352303B (de) Verahren zur herstellung von mono-o-beta- hydroxyaethyl-7-rutin
AT338748B (de) Verfahren zur herstellung von acetoxybutanalen
AT338253B (de) Verfahren zur herstellung von diamiden
AT343131B (de) Verfahren zur herstellung von poly- (n-alkyliminoalanen)
AT340885B (de) Verfahren zur herstellung von acetoacetamid-n-sulfofluorid
AT387375B (de) Kontinuierliches verfahren zur herstellung von chlordioxid
AT340589B (de) Verfahren zur herstellung von delta3-cephalosporinestern
AT342063B (de) Verfahren zur herstellung von 1-phenyl-4-amino-5-chlor-pyridazon (6)
AT374824B (de) Verfahren zur herstellung von reinigungsmittelpulvern
ATA625774A (de) Verfahren zur herstellung von phenylpyridazonen

Legal Events

Date Code Title Description
EIH Change in the person of patent owner
UEP Publication of translation of european patent specification
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee